Los Angeles Capital Management’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-87,723
| Closed | -$447K | – | 1413 |
|
|
2021
Q3 | $447K | Buy |
87,723
+16,000
| +22% | +$81.5K | ﹤0.01% | 1109 |
|
|
2021
Q2 | $454K | Buy |
71,723
+3,190
| +5% | +$20.2K | ﹤0.01% | 1221 |
|
|
2021
Q1 | $530K | Sell |
68,533
-28,016
| -29% | -$217K | ﹤0.01% | 1197 |
|
|
2020
Q4 | $632K | Sell |
96,549
-3,685
| -4% | -$24.1K | ﹤0.01% | 1116 |
|
|
2020
Q3 | $667K | Buy |
100,234
+4,070
| +4% | +$27.1K | ﹤0.01% | 974 |
|
|
2020
Q2 | $801K | Buy |
96,164
+57,500
| +149% | +$479K | ﹤0.01% | 932 |
|
|
2020
Q1 | $297K | Buy |
+38,664
| New | +$297K | ﹤0.01% | 1055 |
|
|
2019
Q2 | – | Sell |
-10,057
| Closed | -$108K | – | 1357 |
|
|
2019
Q1 | $108K | Sell |
10,057
-10,680
| -52% | -$115K | ﹤0.01% | 1334 |
|
|
2018
Q4 | $313K | Sell |
20,737
-215
| -1% | -$3.25K | ﹤0.01% | 1086 |
|
|
2018
Q3 | $388K | Buy |
20,952
+4,520
| +28% | +$83.7K | ﹤0.01% | 1169 |
|
|
2018
Q2 | $376K | Buy |
16,432
+430
| +3% | +$9.84K | ﹤0.01% | 1221 |
|
|
2018
Q1 | $455K | Sell |
16,002
-390
| -2% | -$11.1K | ﹤0.01% | 1062 |
|
|
2017
Q4 | $346K | Buy |
+16,392
| New | +$346K | ﹤0.01% | 1150 |
|